FDA Webview
X

Free FDA Notices

Info on IND Regs Sent to OMB

03/03/2015

Federal Register Notice: FDA’s proposed collection of information, “Investigational New Drug (IND) Regulations — 21 CFR Part 312,” has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.

LATEST NEWS